The new funding rounds, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New funding rounds, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Industry Trends
See who's moving and how much in your market
No credit card required Weekly funding digest
New Limit announced it raised $130 Million in an initial filing from an offering of $130 Million
PRIVATEMay 15, 2025•about 1 year ago
Amount Raised
$130 Million
South San FranciscoBiotechnology
Company Information
Company
NewLimit
Location
South San Francisco, California, United States
About
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
South San FranciscoBiotechnology